系统性硬化症中的炎性关节炎:流行病学、关联因素与疾病负担
基于澳大利亚硬皮病队列研究的前瞻性数据,炎性关节炎在系统性硬化症患者中常见,累及三分之一(33.3%)患者,中位随访4.3年。炎性关节炎与弥漫型系统性硬化症、关节挛缩和肌腱摩擦感、肌炎及干燥症状相关,与肺动脉高压负相关,并与较差的健康相关生活质量和更多躯体残疾相关。
要点
- 炎性关节炎累及33.3%的系统性硬化症患者,中位随访4.3年。
- 炎性关节炎与弥漫型系统性硬化症、关节挛缩和肌腱摩擦感、肌炎及干燥症状相关。
- 炎性关节炎患者健康相关生活质量评分更低、躯体残疾更多。
核心结论
- 炎性关节炎是系统性硬化症常见表现,更多见于弥漫型疾病,与较差的健康相关生活质量和躯体残疾相关。
- 作者认为需要对系统性硬化症中炎性关节炎的有效管理开展进一步研究。
研究设计与样本
- 前瞻性纳入澳大利亚硬皮病队列研究的系统性硬化症患者。
- 炎性关节炎临床定义为体格检查存在滑膜炎。
- 采用逻辑回归分析炎性关节炎与系统性硬化症表现及血清学参数的关联,采用患者报告结局指标评估躯体功能和健康相关生活质量。
主要发现
- 炎性关节炎累及三分之一(33.3%)患者,中位随访4.3(1.7-8.4)年。
- 炎性关节炎与弥漫型系统性硬化症相关(OR 1.33,95%CI 1.01-1.74,P=0.042),与并发肌肉骨骼表现(关节挛缩和肌腱摩擦感)相关(OR 1.70,95%CI 1.34-2.15,P<0.001),与肌炎相关(OR 2.11,95%CI 1.39-3.20,P<0.001),与干燥症状相关(OR 1.57,95%CI 1.14-2.16,P=0.006)。
- 炎性关节炎与肺动脉高压负相关(OR 0.52,95%CI 0.35-0.78,P=0.002)。
- 类风湿因子与U1小核核糖核蛋白抗体均与炎性关节炎无关联(分别为OR 1.13,95%CI 0.88-1.44,P=0.331;OR 1.46,95%CI 0.89-2.39,P=0.129)。
- 抗环瓜氨酸蛋白抗体阳性虽频率低,但在炎性关节炎患者中较无炎性关节炎者更常见(7.5% vs 1.5%,P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为需要对系统性硬化症中炎性关节炎的有效管理开展进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the epidemiology, associations, and impact of inflammatory arthritis (IA) in systemic sclerosis (SSc). METHODS: Patients with SSc prospectively enrolled in the Australian Scleroderma Cohort Study were included. IA was defined clinically as the presence of synovitis on examination. Logistic regression was used to determine the associations of IA with SSc manifestations and serological parameters. Patient-reported outcome measures were used to capture physical function and health-related quality of life (HRQoL). RESULTS: IA was a common SSc manifestation affecting one-third (33.3%) of patients over a median follow-up of 4.3 (1.7-8.4) years. Associations of IA included diffuse SSc (odds ratio [OR] 1.33, 95% confidence interval [95% CI] 1.01-1.74, P = 0.042), concurrent musculoskeletal manifestations (joint contractures and tendon friction rubs, OR 1.70, 95% CI 1.34-2.15, P < 0.001); myositis (OR 2.11, 95% CI 1.39-3.20, P < 0.001), and sicca symptoms (OR 1.57, 95% CI 1.14-2.16, P = 0.006), whereas IA was negatively associated with pulmonary arterial hypertension (OR 0.52, 95% CI 0.35-0.78, P = 0.002). Neither the presence of rheumatoid factor nor U1 small nuclear RNP were associated with IA (OR 1.13, 95% CI 0.88-1.44, P = 0.331, OR 1.46, 95% CI 0.89-2.39, P = 0.129 respectively). Positive anticyclic citrullinated protein antibodies, although at low frequency, were more common in those with IA compared with those without IA (7.5% vs 1.5%, P < 0.001). IA was associated with significantly lower HRQoL score (P < 0.001) and more physical disability than in those without IA (P < 0.001). CONCLUSION: IA is a common disease manifestation that is more frquently seen in diffuse disease. IA is associated with poor HRQoL and physical disability. Further research is needed into the effective management of IA in SSc.
引用
- Schwender E, Hansen D, Stevens W, et al. Inflammatory Arthritis in Systemic Sclerosis: Its Epidemiology, Associations, and Morbidity. Arthritis Care Res (Hoboken). 2024. PMID: 38327022. doi:10.1002/acr.25311
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。